# Cochrane

# Trusted evidence.

# Informed decisions.

# Better health.

# Cochrane Database of Systematic Reviews

# Outcome or subgroup title

|Outcome or subgroup title|No. of studies|No. of participants|Statistical method|Effect size|
|---|---|---|---|---|
|1.12.1 Upper gastrointestinal|2|83|Risk Ratio (M-H, Random, 95% CI)|1.21 [0.32, 4.49]|
|1.12.2 Lower gastrointestinal|7|370|Risk Ratio (M-H, Random, 95% CI)|2.19 [0.92, 5.23]|
|1.12.3 Mixed (upper and lower) route|1|15|Risk Ratio (M-H, Random, 95% CI)|1.14 [0.09, 15.08]|
|1.13 Serious adverse events for induction of remission in UC: subgroup analysis by type of donor|10|468|Risk Ratio (M-H, Random, 95% CI)|1.77 [0.88, 3.55]|
|1.13.1 Single donor|6|191|Risk Ratio (M-H, Random, 95% CI)|2.36 [0.83, 6.69]|
|1.13.2 Multiple donors|4|277|Risk Ratio (M-H, Random, 95% CI)|1.40 [0.55, 3.58]|
|1.14 Serious adverse events for induction of remission in UC: subgroup analysis by age|10|468|Risk Ratio (M-H, Random, 95% CI)|1.77 [0.88, 3.55]|
|1.14.1 Children|1|25|Risk Ratio (M-H, Random, 95% CI)|4.62 [0.63, 34.05]|
|1.14.2 Adults|9|443|Risk Ratio (M-H, Random, 95% CI)|1.55 [0.73, 3.26]|
|1.15 Serious adverse events for induction of remission in UC: sensitivity analysis using fixed-effect model|10|468|Risk Ratio (M-H, Fixed, 95% CI)|1.87 [0.95, 3.68]|
|1.16 Serious adverse events for induction of remission in UC: sensitivity analysis for available cases|10|382|Risk Ratio (M-H, Random, 95% CI)|1.74 [0.88, 3.47]|
|1.17 Any adverse events for induction of remission in UC|9|417|Risk Ratio (M-H, Random, 95% CI)|0.99 [0.85, 1.16]|
|1.18 Induction of endoscopic remission in UC at longest follow-up|5|285|Risk Ratio (M-H, Random, 95% CI)|1.45 [0.64, 3.29]|
|1.19 Quality of life (Inflammatory Bowel Disease Questionnaire [IBDQ]) scores at longest follow-up for induction of remission in UC|3|131|Mean Difference (IV, Random, 95% CI)|15.34 [-3.84, 34.52]|
|1.20 Quality of life (IBDQ) scores at longest follow-up for induction of remission in UC: sensitivity analysis without Haifer 2022|2|96|Mean Difference (IV, Random, 95% CI)|22.20 [0.63, 43.78]|
|1.21 Induction of clinical response in UC at longest follow-up|10|468|Risk Ratio (M-H, Random, 95% CI)|1.33 [0.96, 1.84]|
|1.22 Induction of endoscopic response in UC at longest follow-up|3|164|Risk Ratio (M-H, Random, 95% CI)|1.48 [0.79, 2.76]|

# Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright Â© 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.